Direct Dosing of Preweaning Rodents in Toxicity Testing and Research: Deliberations of an ILSI RSI Expert Working Group
- 1 March 2005
- journal article
- research article
- Published by SAGE Publications in International Journal of Toxicology
- Vol. 24 (2) , 87-94
Abstract
Laboratory animal studies designed to assess the effects of exposure of a test substance during postnatal development are commonly utilized in basic research and to evaluate potential hazard to children for chemical and pharmaceutical regulation. Direct dosing, defined here as the administration of a test substance directly to a preweaning mammal, has been identified as a useful tool that can be used in the conduct of such studies for regulatory purposes. The International Life Sciences Institute Risk Science Institute (ILSI RSI) convened an Expert Working Group to develop guidance on the design and implementation of direct dosing regulatory studies on preweaning mammals, which was published as an ILSI monograph in 2003 (Zoetis and Walls, Principles and Practices for Direct Dosing of Pre-Weaning Mammals in Toxicity Testing and Research, Washington, DC: ILSI Press, 2003). A summary of the Working Group conclusions regarding direct dosing studies with laboratory rodents are presented here, although the ILSI monograph also includes rabbits, canines, swine and nonhuman primates. Issues to be considered when designing the protocol include selection of the test species, the route of administration, dose levels, and the timing of dosing. Knowledge of the maturational status of the test species and information on critical windows of development are important in creating a valid study design. Most common routes of administration (e.g., oral, inhalation, injection) are possible with typical laboratory species; however, adjustments may be necessary due to practical considerations. Information on the pharmacokinetic profile in young animals versus adults and in the test species versus humans is very useful for determining dosing parameters. The conduct of the study and the interpretation of the data will be improved by an understanding of confounding factors as well as statistical and biological issues specific for postnatal studies. Ultimately, the success of the study will depend upon careful preparation, including thorough training of the technical staff.Keywords
This publication has 34 references indexed in Scilit:
- Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicantsToxicology and Applied Pharmacology, 2004
- Comparative organ system development: Continuing the seriesBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
- Species comparison of anatomical and functional immune system developmentBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
- Comparative organ system development: IntroductionBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
- Landmarks in the development of the female reproductive systemBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
- Development and maturation of the male reproductive systemBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
- Whole Body Pharmacokinetic ModelsClinical Pharmacokinetics, 2003
- DEVELOPMENT OF AN INHALATION SYSTEM FOR THE SIMULTANEOUS EXPOSURE OF RAT DAMS AND PUPS DURING DEVELOPMENTAL NEUROTOXICITY STUDIESInhalation Toxicology, 1998
- Toxicity evaluations of l-cysteine and Procysteine™, a cysteine prodrug, given once intravenously to neonatal ratsToxicology Letters, 1993
- Proteins in cerebrospinal fluid and plasma of fetal rats during developmentDevelopmental Biology, 1981